Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales of ...
Find insight on Siemens Healthineers, WeChat, Apple, U.S. tariffs and more in the latest Market Talks covering Technology, Media and Telecom.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback